¹⁸F-FDG PET/MRI in cryptogenic new-onset refractory status epilepticus: a potential marker of disease location, activity and prognosis?

J Neurol Sci. 2017 Oct 15:381:100-102. doi: 10.1016/j.jns.2017.08.021. Epub 2017 Aug 17.

Authors

L Nardetto¹, M Zoccarato², L Santelli², I Tiberio³, D Cecchin⁴, B Giometto²

Affiliations

¹ Neurology Department, Ospedale S. Antonio, Padova, Italy. Electronic address: [email protected].
² Neurology Department, Ospedale S. Antonio, Padova, Italy.
³ Intensive Care Unit, Ospedale S. Antonio, Padova, Italy.
⁴ Department of Medicine DIMED, University-Hospital of Padova, Italy.

PMID: 28991656
DOI: 10.1016/j.jns.2017.08.021

No abstract available

Keywords: 18F-FDG PET/MRI; New-onset refractory status epilepticus (NORSE); Temporal lobe epilepsy.

Publication types

Case Reports
Letter

MeSH terms

Brain / diagnostic imaging*
Brain / metabolism
Drug Resistance
Female
Fluorodeoxyglucose F18*
Glucose / metabolism
Humans
Magnetic Resonance Imaging
Positron-Emission Tomography*
Prognosis
Radiopharmaceuticals*
Status Epilepticus / diagnostic imaging*
Status Epilepticus / metabolism
Status Epilepticus / therapy
Young Adult

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18
Glucose